Related references
Note: Only part of the references are listed.Vancomycin Treatment's Association with Delayed Intestinal Tissue Injury, Clostridial Overgrowth, and Recurrence of Clostridium difficile Infection in Mice
Cirle A. Warren et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection
D. Bosse et al.
INFECTION (2013)
Adaptive Strategies and Pathogenesis of Clostridium difficile from In Vivo Transcriptomics
Claire Janoir et al.
INFECTION AND IMMUNITY (2013)
Fidaxomicin inhibits toxin production in Clostridium difficile
Farah Babakhani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Multiple Factors Modulate Biofilm Formation by the Anaerobic Pathogen Clostridium difficile
Tanja Dapa et al.
JOURNAL OF BACTERIOLOGY (2013)
Effects of ciprofloxacin on the expression and production of exotoxins by Clostridium difficile
Michael John Aldape et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2013)
Fidaxomicin Inhibits Spore Production in Clostridium difficile
Farah Babakhani et al.
CLINICAL INFECTIOUS DISEASES (2012)
Characterisation of Clostridium difficile Biofilm Formation, a Role for Spo0A
Lisa F. Dawson et al.
PLOS ONE (2012)
Tigecycline for the Treatment of Severe Clostridium difficile Infection
Kelly C. Larson et al.
ANNALS OF PHARMACOTHERAPY (2011)
Relapse Versus Reinfection: Surveillance of Clostridium difficile Infection
Mini Kamboj et al.
CLINICAL INFECTIOUS DISEASES (2011)
Mouse Relapse Model of Clostridium difficile Infection
Xingmin Sun et al.
INFECTION AND IMMUNITY (2011)
Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile
Tarun Mathur et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Lack of Association between Clinical Outcome of Clostridium difficile Infections, Strain Type, and Virulence-Associated Phenotypes
Stephanie Sirard et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Treatment of refractory and recurrent Clostridium difficile infection
Christina M. Surawicz et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Reconsidering the Sporulation Characteristics of Hypervirulent Clostridium difficile BI/NAP1/027
David A. Burns et al.
PLOS ONE (2011)
Severe and refractory Clostridium difficile infection successfully treated with tigecycline and metronidazole
Ching-Lan Lu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Effects of Subinhibitory Concentrations of Antibiotics on Colonization Factor Expression by Moxifloxacin-Susceptible and Moxifloxacin-Resistant Clostridium difficile Strains
Cecile Deneve et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Typing Clostridium difficile strains based on tandem repeat sequences
N. Henning Zaiss et al.
BMC MICROBIOLOGY (2009)
Intravenous Tigecycline as Adjunctive or Alternative Therapy for Severe Refractory Clostridium difficile Infection
Bjorn L. Herpers et al.
CLINICAL INFECTIOUS DISEASES (2009)
Antibiotic Treatment of Clostridium difficile Carrier Mice Triggers a Supershedder State, Spore-Mediated Transmission, and Severe Disease in Immunocompromised Hosts
Trevor D. Lawley et al.
INFECTION AND IMMUNITY (2009)
Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model
Simon D. Baines et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model
Urs A. Ochsner et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Recurrent Clostridium difficile infection: A review of risk factors, treatments, and outcomes
Stuart Johnson
JOURNAL OF INFECTION (2009)
Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea
Ju Young Chang et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Microarray analysis of the transcriptional responses of Clostridium difficile to environmental and antibiotic stress
Jenny E. Emerson et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2008)
Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile
Michael Gerber et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2008)
Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains
Warren N. Fawley et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
Effect of tigecycline on normal oropharyngeal and intestinal microflora
Carl Erik Nord et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Emergence of Clostridium difficile-associated disease in North America and Europe
E. J. Kuijper et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada
J Pépin et al.
CLINICAL INFECTIOUS DISEASES (2006)
A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality
VG Loo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea:: A cohort study during an epidemic in Quebec
J Pépin et al.
CLINICAL INFECTIOUS DISEASES (2005)
Treatment of Clostridium difficile-associated disease: old therapies and new strategies
S Aslam et al.
LANCET INFECTIOUS DISEASES (2005)
Genotypic differentiation of twelve Clostridium species by polymorphism analysis of the triosephosphate isomerase (tpi) gene
A Dhalluin et al.
SYSTEMATIC AND APPLIED MICROBIOLOGY (2003)
Breaking the cycle:: Treatment strategies for 163 cases of recurrent Clostridium difficile disease
LV McFarland et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2002)
Hospital disinfectants and spore formation by Clostridium difficile
MH Wilcox et al.
LANCET (2000)
Share Paper
